Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors

被引:18
|
作者
Shi, Lei [1 ]
Yang, Ying [1 ]
Li, Zi-Lin [1 ]
Zhu, Zhen-Wei [1 ]
Liu, Chang-Hong [1 ]
Zhu, Hai-Liang [1 ]
机构
[1] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China
基金
美国国家科学基金会;
关键词
Monoamine oxidase; Inhibitors; Nicotinamides; Structure-activity relationship; Molecular docking; CRYSTAL-STRUCTURES; DRUG TARGET; MAO-B; BRAIN; ANTIDEPRESSANTS; POPULATIONS; DISEASE; BINDING;
D O I
10.1016/j.bmc.2009.12.065
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of N-(2-morpholinoethyl)nicotinamide (1-13) and N-(3-morpholinopropyl)nicotinamide derivatives (14-26) have been designed, synthesized and evaluated in vitro for their monoamine oxidase (MAO) A and B inhibitory activity and selectivity. Most of these synthesized compounds proved to be potent, and selective inhibitors of MAO-A rather than of MAO-B. 5-Chloro-6-hydroxy-N-(2-morpholinoethyl)nicotinamide (13) displayed the highest MAO-A inhibitory potency (IC50 = 0.045 mu M) and a good selectivity. 2-Bromo-N-(2-morpholinoethyl)nicotinamide (3) was the most potent MAO-B inhibitor with the IC50 value of 0.32 mu M, but it was not selective. Molecular dockings of compound 13 were performed in order to give structural insights regarding the MAO-A selectivity. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1659 / 1664
页数:6
相关论文
共 50 条
  • [1] Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors
    Hammuda, Arwa
    Shalaby, Raed
    Rovida, Stefano
    Edmondson, Dale E.
    Binda, Claudia
    Khalil, Ashraf
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 114 : 162 - 169
  • [2] DESIGN AND SYNTHESIS OF NOVEL AND POTENT MONOAMINE-OXIDASE INHIBITORS
    BRANCA, Q
    JAKOBROTNE, R
    KETTLER, R
    ROVER, S
    SCALONE, M
    CHIMIA, 1995, 49 (10) : 381 - 385
  • [3] Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B
    Van der Walt, Mietha M.
    Terre'Blanche, Gisella
    Petzer, Jacobus P.
    Petzer, Anel
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 : 1193 - 1199
  • [4] Sulfanylphthalonitrile analogues as selective and potent inhibitors of monoamine oxidase B
    Van der Walt, Mietha M.
    Terre'Blanche, Gisella
    Lourens, Anna C. U.
    Petzer, Anel
    Petzer, Jacobus P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (24) : 7367 - 7370
  • [5] Simple, potent, and selective pyrrole inhibitors of monoamine oxidase types A and B
    Silvestri, R
    La Regina, G
    De Martino, G
    Artico, M
    Befani, O
    Palumbo, M
    Agostinelli, E
    Turini, P
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (06) : 917 - 920
  • [6] Novel Arylalkenylpropargylamines as Neuroprotective, Potent, and Selective Monoamine Oxidase B Inhibitors for the Treatment of Parkinson's Disease
    Huleatt, Paul B.
    Khoo, Mui Ling
    Chua, Yi Yuan
    Tan, Tiong Wei
    Liew, Rou Shen
    Balogh, Balazs
    Deme, Ruth
    Goeloencser, Flora
    Magyar, Kalman
    Sheela, David P.
    Ho, Han Kiat
    Sperlagh, Beata
    Matyus, Peter
    Chai, Christina L. L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (03) : 1400 - 1419
  • [7] Novel sulfanylphthalimide analogues as highly potent inhibitors of monoamine oxidase B
    Van der Walt, Mietha M.
    Terre'Blanche, Gisella
    Petzer, Anel
    Petzer, Jacobus P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (21) : 6632 - 6635
  • [8] In silico identification of novel and selective monoamine oxidase B inhibitors
    Kemal Yelekçi
    Bora Büyüktürk
    Nurdan Kayrak
    Journal of Neural Transmission, 2013, 120 : 853 - 858
  • [9] In silico identification of novel and selective monoamine oxidase B inhibitors
    Yelekci, Kemal
    Buyukturk, Bora
    Kayrak, Nurdan
    JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (06) : 853 - 858
  • [10] ALIPHATIC PROPARGYLAMINES - POTENT, SELECTIVE, IRREVERSIBLE MONOAMINE OXIDASE-B INHIBITORS
    YU, PH
    DAVIS, BA
    BOULTON, AA
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (20) : 3705 - 3713